Remicade (infliximab)

BIOLOGICAL4 trials

Sponsors

Oregon Health and Science University, Merck Sharp & Dohme LLC, Samsung Bioepis Co., Ltd.

Conditions

Arthritis, PsoriaticCrohn's DiseaseRheumatoid ArthritisUveitis

Phase 3

A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

CompletedNCT01936181

Samsung Bioepis Co., Ltd.Rheumatoid Arthritis

Start: 2013-08-31End: 2015-09-30Updated: 2017-09-14

Unknown Phase

A Clinical Trial of Infliximab for Uveitis

CompletedNCT00273390

Oregon Health and Science UniversityUveitis

Start: 2001-08-31End: 2006-12-31Target: 32Updated: 2011-07-04

Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)

CompletedNCT00725296

Merck Sharp & Dohme LLCArthritis, Psoriatic

Start: 2004-12-31End: 2010-07-31Updated: 2015-11-05

Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)

CompletedNCT00818272

Merck Sharp & Dohme LLCCrohn's Disease

Start: 2002-12-31End: 2010-12-31Updated: 2015-09-03

Related Papers

Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis

Scandinavian Journal of Rheumatology2020-05-291 citations

Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis

RMD Open2020-01-015 citations

Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study.

2017-10-1794 citations

Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results

Lara D. Veeken2017-07-1854 citations

A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy

Annals of the Rheumatic Diseases2015-12-01165 citations